Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial
J Clin Oncol. 2025 Oct 20:JCO2500992. doi: 10.1200/JCO-25-00992.…
Specific targeting of the pseudogene RPSAP52 reduces ovarian tumor growth in patient-derived orthoxenograft models
Eur J Cancer. 2025 Oct 3;230:116040. doi: 10.1016/j.ejca.2025.116040.…
Evolution of angiogenic and inflammatory biomarkers in patients with hereditary hemorrhagic telangiectasia during treatment with bevacizumab: study protocol
Rev Clin Esp (Barc). 2025 Oct 5:502370. doi: 10.1016/j.rceng.2025.502370.…
Impact of the national blackout of April 28, 2025 on processing facilities for hematopoietic stem cell transplantation and cell therapy in Spain
Transfus Apher Sci. 2025 Sep 30;64(6):104257. doi: 10.1016/j.transci.2025.104257.…
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee
J Eur Acad Dermatol Venereol. 2025 Oct 1. doi: 10.1111/jdv.70042.…
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
Bone Marrow Transplant. 2025 Oct 1. doi: 10.1038/s41409-025-02696-x.…
Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease
Haematologica. 2025 Sep 25. doi: 10.3324/haematol.2025.288307.…
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Blood Adv. 2025 Sep 24:bloodadvances.2025017081. doi: 10.1182/bloodadvances.2025017081.…
Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma
Am J Hematol. 2025 Sep 20. doi: 10.1002/ajh.70077. Online ahead…
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 patients
Clin Cancer Res. 2025 Sep 12. doi: 10.1158/1078-0432.CCR-25-1513.…
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma
Blood. 2025 Sep 8:blood.2025029909. doi: 10.1182/blood.2025029909.…
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian Hamsters
Hum Gene Ther. 2025 Aug 29. doi: 10.1177/10430342251372091. Online…
